Fanny Wunder
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Advanced Breast Cancer Therapies 2
- Oncology 6
- Pancreatic and Hepatic Oncology Research 2
- Lung Cancer Research Studies 2
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Richard L. Schilsky (3 shared papers)Pierre Saintigny (4 shared papers)Enriqueta Felip (3 shared papers)Razelle Kurzrock (8 shared papers)Amir Onn (5 shared papers)Eitan Rubin (7 shared papers)Catherine Bresson (8 shared papers)Jacques Raynaud (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Therapeutic Advances in Medical Oncology (2 papers)Annals of Oncology (2 papers)Frontiers in Pharmacology (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Fanny Wunder
7 papers receiving 19 citations
Peers
Comparison fields: 5 of 16
- Cancer Research 10
- Pulmonary and Respiratory Medicine 10
- Oncology 8
- Toxicology 1
- Reproductive Medicine 2
Countries citing papers authored by Fanny Wunder
This map shows the geographic impact of Fanny Wunder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Wunder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Wunder more than expected).
Fields of papers citing papers by Fanny Wunder
This network shows the impact of papers produced by Fanny Wunder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Wunder. The network helps show where Fanny Wunder may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanny Wunder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2018 | 5 | |
| 3 | 2019 | 3 | |
| 4 | 2020 | 2 | |
| 5 | 2017 | 1 | |
| 6 | 2014 | 1 | |
| 7 | 2014 | 1 | |
| 8 | 2025 | 0 | |
| 9 | 2024 | 0 | |
| 10 | 2025 | 0 |
About Fanny Wunder
Fanny Wunder is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 10 papers that have together received 20 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Genomics and Diagnostics (4 papers), Genetic factors in colorectal cancer (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Advanced Breast Cancer Therapies (2 papers), Lung Cancer Research Studies (2 papers), Colorectal Cancer Treatments and Studies (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Cancer Research (10 citations), Pulmonary and Respiratory Medicine (10 citations), Oncology (8 citations), Toxicology (1 citation) and Reproductive Medicine (2 citations). Fanny Wunder has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Richard L. Schilsky, Pierre Saintigny, Enriqueta Felip, Razelle Kurzrock, Amir Onn, Eitan Rubin, Catherine Bresson, Jacques Raynaud, Vladimir Lazar and Marine Gross‐Goupil. Their work appears in journals such as Journal of Clinical Oncology, Therapeutic Advances in Medical Oncology, Annals of Oncology, Frontiers in Pharmacology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.